Company intelligence / Profile preview

DIVERSA Technologies

Santiago de Compostela, Galicia, Spaindiversatechnologies.com ↗

Ownership: Private
Development stage: Other

Overview

DIVERSA provides a patented, highly stable lipid nanoemulsion platform for efficient delivery of a wide range of therapeutic molecules (small molecules, peptides, proteins, DNA/RNA) and shows promising biocompatibility and stability in biological fluid models.

Therapeutic areas: ImmunologyRheumatologyInfectious DiseasesMetabolic DisordersRare DiseasesDermatologyOncology
Modalities: Lipid nanoparticle delivery therapyNanoparticleSmall moleculePeptidesProteinsRNA therapy (including mRNA, siRNA, miRNA, aptamers)
Industry: Biotech

Partnerships

Research/technology partnerships with pharma, biotech, and academics (e.g., Santiago de Compostela Health Research Institute, Galician Health Service/IDIS/SERGAS)Collaborations with CDMOs for GMP manufacturing

Beyond the preview

Go deeper on DIVERSA Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DIVERSA Technologies.